iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
The investigators developed iChoose Kidney -- a shared decision-making support tool
 accessible through iPad, iPhone, or the web -- to provide ESRD patients and their providers
 with a simple, standardized, easily accessible, statistically robust tool for use in the
 clinic to guide patient education and healthcare decision-making about treatment options of
 dialysis or kidney transplantation. The iChoose Kidney decision aid provides patients with
 estimates of their individualized 1 and 3-year risks of mortality on dialysis vs.
 transplantation, based on previous national data. The tool has the potential to improve
 communication and decision-making between patients and their healthcare providers and improve
 access to kidney transplantation among patients with ESRD.

 This will be a two-arm, randomized study, and will be conducted at 3 large transplant centers
 with diverse patient populations. One group of patients will receive standard education alone
 during their scheduled transplant evaluation. The second group will receive the standard
 education as well have the provider use the iChoose Kidney aid with them. The project
 timeline will be a total of 24 months inclusive of enrollment, follow-up, data analysis, and
 outcome evaluation.

 This study will assess how well the iChoose decision aid works in improving patient
 knowledge, preferences for treatment, and patient access to transplant. The study will also
 assess whether providers find the tool useful for providing ways to share information with
 patients about ways to treat their kidney disease.
Inclusion Criteria:

 -  Diagnosis of end-stage renal disease (ESRD) and on dialysis for < 1 year

 -  English-speaking

 -  Subjects coming in for transplant medical evaluation

 -  Age > 18 years

 Exclusion Criteria:

 -  Severe cognitive or visual impairment